Penta Valent
PT. Penta Valent Tbk distributes pharmaceutical products, medical equipment, and consumer products in Indonesia. It operates through Pharmaceutical Products and Consumer Goods segments. The company offers prescription medicinal products; over the counter drug products; medical supporting equipment, such as blood pressure meters, body thermometers, and others; reaction materials, such as blood sug… Read more
Market Cap & Net Worth: Penta Valent (PEVE)
Penta Valent (JK:PEVE) has a market capitalization of $52.09 Million (Rp847.50 Billion) as of March 19, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #28709 globally and #457 in its home market, demonstrating a -4.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Penta Valent's stock price Rp480.00 by its total outstanding shares 1765625000 (1.77 Billion).
Penta Valent Market Cap History: 2023 to 2026
Penta Valent's market capitalization history from 2023 to 2026. Data shows growth from $18.45 Million to $52.09 Million (32.09% CAGR).
Index Memberships
Penta Valent is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Jakarta Stock Exchange Composite Index
JKSE
|
$129.13 Billion | 0.01% | #426 of 864 |
Weight: Penta Valent's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Penta Valent Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Penta Valent's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Penta Valent's market cap is 0.00 times its annual revenue
8.08x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
Penta Valent's market cap is 0.00 times its annual earnings
1.78x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $18.45 Million | $2.48 Trillion | $36.17 Billion | 0.00x | 0.00x |
| 2024 | $30.39 Million | $3.01 Trillion | $48.01 Billion | 0.00x | 0.00x |
Competitor Companies of PEVE by Market Capitalization
Companies near Penta Valent in the global market cap rankings as of March 19, 2026.
Key companies related to Penta Valent by market ranking:
- Alibaba Health Information Technology Limited (PINK:ALBBY): Ranked #1419 globally with a market cap of $12.50 Billion USD.
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #1876 globally with a market cap of $8.58 Billion USD.
- Raia Drogasil S.A (SA:RADL3): Ranked #2751 globally with a market cap of $5.08 Billion USD ( R$30.91 Billion BRL).
- Clicks Group Ltd (PINK:CLCGY): Ranked #2856 globally with a market cap of $4.80 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1419 | Alibaba Health Information Technology Limited | PINK:ALBBY | $12.50 Billion | $12.32 |
| #1876 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $8.58 Billion | $11.98 |
| #2751 | Raia Drogasil S.A | SA:RADL3 | $5.08 Billion | R$23.58 |
| #2856 | Clicks Group Ltd | PINK:CLCGY | $4.80 Billion | $35.11 |
Penta Valent Historical Marketcap From 2023 to 2026
Between 2023 and today, Penta Valent's market cap moved from $18.45 Million to $ 52.09 Million, with a yearly change of 32.09%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp52.09 Million | -12.73% |
| 2025 | Rp59.69 Million | +96.43% |
| 2024 | Rp30.39 Million | +64.71% |
| 2023 | Rp18.45 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Penta Valent was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $52.09 Million USD |
| MoneyControl | $52.09 Million USD |
| MarketWatch | $52.09 Million USD |
| marketcap.company | $52.09 Million USD |
| Reuters | $52.09 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.